.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Johnson and Johnson
Cipla
US Army
QuintilesIMS
Farmers Insurance
Medtronic
Accenture
Citi
Chinese Patent Office

Generated: December 13, 2017

DrugPatentWatch Database Preview

ARTANE Drug Profile

« Back to Dashboard

When do Artane patents expire, and when can generic versions of Artane launch?

Artane is a drug marketed by Lederle and is included in two NDAs.

The generic ingredient in ARTANE is trihexyphenidyl hydrochloride. There are three drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the trihexyphenidyl hydrochloride profile page.
Drug patent expirations by year for ARTANE

Medical Subject Heading (MeSH) Categories for ARTANE

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
LederleARTANEtrihexyphenidyl hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL006773-010Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
LederleARTANEtrihexyphenidyl hydrochlorideTABLET;ORAL006773-005Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
LederleARTANEtrihexyphenidyl hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL012947-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
LederleARTANEtrihexyphenidyl hydrochlorideELIXIR;ORAL006773-009Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
LederleARTANEtrihexyphenidyl hydrochlorideTABLET;ORAL006773-003Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Cipla
Colorcon
Cantor Fitzgerald
Teva
Citi
Baxter
Novartis
Mallinckrodt
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot